Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

oxyCODONE-naltrexone

oxyCODONE-naltrexone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Troxyca ER CAPSULE, EXTENDED RELEASE, ORAL 10 mg-1.2 mg, 20 mg-2.4 mg, 30 mg-3.6 mg, 40 mg-4.8 mg    
Troxyca ER CAPSULE, EXTENDED RELEASE, ORAL 60 mg-7.2 mg, 80 mg-9.6 mg    
Comments:

Troxyca medication guide

Ordered Formulation Therapeutic Interchange Notes

oxyCODONE-naltrexone (Troxyca ER)

  • 10 mg-1.2 mg ER capsule BID
  • 20 mg-2.4 mg ER capsule BID
  • 30 mg-3.6 mg ER capsule BID
  • 40 mg-4.8 mg ER capsule BID
  • 60 mg-7.2 mg ER capsule BID
  • 80 mg-9.6 mg ER capsule BID

oxyCODONE (OxyCONTIN)

  • 10 mg ER tablet BID
  • 20 mg ER tablet BID
  • 30 mg ER tablet BID
  • 40 mg ER tablet BID
  • 40 mg ER tablet Q8hrs
  • 80 mg ER tablet BID

Note dosing interval of 60 mg-7.2 mg tablet is not BID.

Non-formulary. Will be interchanged to oxyCODONE ER without naltrexone.

Reviewed: 23 May 2017 (Troxyca ER)

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved